MYC promotes cancer progression by modulating m6 A modifications to suppress target gene translation

EMBO Rep. 2021 Mar 3;22(3):e51519. doi: 10.15252/embr.202051519. Epub 2021 Jan 11.

Abstract

The MYC oncoprotein activates and represses gene expression in a transcription-dependent or transcription-independent manner. Modification of mRNA emerges as a key gene expression regulatory nexus. We sought to determine whether MYC alters mRNA modifications and report here that MYC promotes cancer progression by down-regulating N6-methyladenosine (m6 A) preferentially in transcripts of a subset of MYC-repressed genes (MRGs). We find that MYC activates the expression of ALKBH5 and reduces m6 A levels in the mRNA of the selected MRGs SPI1 and PHF12. We also show that MYC-regulated m6 A controls the translation of MRG mRNA via the specific m6 A reader YTHDF3. Finally, we find that inhibition of ALKBH5, or overexpression of SPI1 or PHF12, effectively suppresses the growth of MYC-deregulated B-cell lymphomas, both in vitro and in vivo. Our findings uncover a novel mechanism by which MYC suppresses gene expression by altering m6 A modifications in selected MRG transcripts promotes cancer progression.

Keywords: ALKBH5; MYC; MYC-repressed genes; m6A; oncogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine
  • AlkB Homolog 5, RNA Demethylase* / genetics
  • AlkB Homolog 5, RNA Demethylase* / metabolism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasms* / genetics
  • RNA, Messenger / genetics

Substances

  • RNA, Messenger
  • AlkB Homolog 5, RNA Demethylase
  • Adenosine

Associated data

  • GEO/GSE150892